It has also been reported that for patients with advanced pancreatic cancer who undergo palliative chemotherapy before resection, patients with preserved SMAD4 expression have significantly shorter progression-free survival than patients with lost SMAD4 expression [25]. The gene discussed is SMAD4; the disease is pancreatic neoplasm.